{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:50Z","timestamp":1740135530906,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim was to evaluate the effect of metabolic control on bone biomarkers in children with type I diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>The children were divided into two groups according to their glycated hemoglobin (HbA1c) (%) levels: a group with HbA1c levels\u2009&lt;\u20098% (<jats:italic>n<\/jats:italic>\u2009=\u200916) and: a group with HbA1c levels\u2009&gt;\u20098% (<jats:italic>n<\/jats:italic>\u2009=\u200918). The serum total oxidative status (TOS) (\u00b5mol\/L), total antioxidant status (TAS) (mmol\/L), alkaline phosphatase (ALP) (IU\/L), osteocalcin (OC) (ng\/ml), procollagen type-1-N-terminal peptide (P1NP) (ng\/ml), and vitamin D (IU) levels and food consumption frequencies were determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>When patients were classified according to HbA1c (%) levels, those with HbA1c levels\u2009&lt;\u20098% were found to have lower TOS (\u00b5mol\/L) values (8.7\u2009\u00b1\u20096.16, 9.5\u2009\u00b1\u20095.60) and higher serum OC (ng\/mL) (24.2\u2009\u00b1\u200916.92, 22.0\u2009\u00b1\u20096.21) levels than those with HbA1c levels\u2009&gt;\u20098% (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Regardless of the level of metabolic control, there was a statistically significant association between serum TOS (\u00b5mol\/L) and P1NP (ng\/ml) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) levels, with no group-specific relationship (HbA1c levels &lt;%8 or HbA1c levels &gt;%8).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HbA1c and serum TOS levels had an effect on bone turnover biomarkers in individuals with type I diabetes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-024-01553-0","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:45:55Z","timestamp":1718336755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does metabolic control of the disease related with bone turnover markers in children with type 1 diabetes mellitus in Turkey?"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-6543","authenticated-orcid":false,"given":"Merve Sena","family":"Topkaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8430-5519","authenticated-orcid":false,"given":"Onur","family":"Ak\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-2586","authenticated-orcid":false,"given":"Tu\u011fba K\u00fc\u00e7\u00fckkasap","family":"C\u00f6mert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"10","key":"1553_CR1","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2337\/dc15-0783","volume":"38","author":"DR Weber","year":"2015","unstructured":"Weber DR, Haynes K, Leonard MB, Willi SM, Denburg MR. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the Health Improvement Network (THIN). Diabetes Care. 2015;38(10):1913\u201320.","journal-title":"Diabetes Care"},{"doi-asserted-by":"crossref","unstructured":"N\u00f3voa Y, de La Cuesta A, Caballero E, de Gauna MR, Quinteiro S, Dom\u00ednguez A et al. Epidemiology of childhood-onset type 1 diabetes in Gran Canaria (2006\u20132018). Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed). 2020;67(10):658\u201364.","key":"1553_CR2","DOI":"10.1016\/j.endien.2020.11.003"},{"issue":"6","key":"1553_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00223-017-0381-1","volume":"102","author":"R Franceschi","year":"2018","unstructured":"Franceschi R, Longhi S, Cauvin V, Fassio A, Gallo G, Lupi F, et al. Bone geometry, quality, and bone markers in children with type 1 diabetes mellitus. Calcif Tissue Int. 2018;102(6):657\u201365.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1553_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11914-009-0014-3","volume":"7","author":"P Garnero","year":"2009","unstructured":"Garnero P. Bone markers in osteoporosis. Curr Osteoporos Rep. 2009;7(3):84\u201390.","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"1553_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/pedi.12987","volume":"21","author":"JOB Madsen","year":"2020","unstructured":"Madsen JOB, Herskin CW, Zerahn B, J\u00f8rgensen NR, Olsen BS, Pociot F, et al. Decreased markers of bone turnover in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2020;21(3):505\u201314.","journal-title":"Pediatr Diabetes"},{"doi-asserted-by":"crossref","unstructured":"Al-Hariri M. Sweet bones: the pathogenesis of bone alteration in diabetes. Journal of diabetes research. 2016;2016.","key":"1553_CR6","DOI":"10.1155\/2016\/6969040"},{"issue":"9","key":"1553_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circul Res. 2010;107(9):1058\u201370.","journal-title":"Circul Res"},{"key":"1553_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00223-017-0327-7","volume":"101","author":"M Bacevic","year":"2017","unstructured":"Bacevic M, Brkovic B, Albert A, Rompen E, Radermecker RP, Lambert F. Does oxidative stress play a role in altered characteristics of diabetic bone? A systematic review. Calcif Tissue Int. 2017;101:553\u201363.","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"1553_CR9","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1210\/jc.2006-0711","volume":"91","author":"J L\u00e9ger","year":"2006","unstructured":"L\u00e9ger J, Marinovic D, Alberti C, Dorgeret S, Chevenne D, Marchal, CLv, et al. Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement. J Clin Endocrinol Metabolism. 2006;91(10):3947\u201353.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"4","key":"1553_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41390-020-01197-5","volume":"89","author":"D El Amrousy","year":"2021","unstructured":"El Amrousy D, El-Afify D, Shabana A. Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus. Pediatr Res. 2021;89(4):878\u201381.","journal-title":"Pediatr Res"},{"issue":"10","key":"1553_CR11","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1210\/jc.2019-00035","volume":"104","author":"DR Weber","year":"2019","unstructured":"Weber DR, Gordon RJ, Kelley JC, Leonard MB, Willi SM, Hatch-Stein J, et al. Poor glycemic control is associated with impaired bone accrual in the year following a diagnosis of type 1 diabetes. J Clin Endocrinol Metabolism. 2019;104(10):4511\u201320.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"Supplement1","key":"1553_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/dc11-S011","volume":"34","author":"AD Association","year":"2011","unstructured":"Association AD. Standards of medical care in diabetes\u20142011. Diabetes Care. 2011;34(Supplement1):11\u2013S61.","journal-title":"Diabetes Care"},{"key":"1553_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1651-2227.2006.tb02378.x","volume":"95","author":"WMGRS Group","year":"2006","unstructured":"Group WMGRS, de Onis M. WHO Child Growth standards based on length\/height, weight and age. Acta Paediatr. 2006;95:76\u201385.","journal-title":"Acta Paediatr"},{"issue":"4","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37(4):277\u201385.","journal-title":"Clin Biochem"},{"issue":"12","key":"1553_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103\u201311.","journal-title":"Clin Biochem"},{"issue":"4","key":"1553_CR16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5799\/ahinjs.01.2013.04.0330","volume":"4","author":"M \u00c7idem","year":"2013","unstructured":"\u00c7idem M, Seher K, Hakan S, \u00d6zkaya M, Karaca \u0130. Yayg\u0131n kas-iskelet a\u011fr\u0131s\u0131 olan hastalarda D vitamini eksikli\u011fi prevalans\u0131 ve risk fakt\u00f6rleri. J Clin Experimental Investigations. 2013;4(4):488\u201391.","journal-title":"J Clin Experimental Investigations"},{"issue":"5","key":"1553_CR17","first-page":"814","volume":"7","author":"V Kalaiselvi","year":"2013","unstructured":"Kalaiselvi V, Prabhu K, Ramesh M, Venkatesan V. The association of serum osteocalcin with the bone mineral density in post menopausal women. J Clin Diagn Research: JCDR. 2013;7(5):814.","journal-title":"J Clin Diagn Research: JCDR"},{"issue":"2","key":"1553_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/8756-3282(96)00165-2","volume":"19","author":"O \u00d8rum","year":"1996","unstructured":"\u00d8rum O, Hansen M, Jensen CH, S\u00f8rensen H, Jensen L, H\u00f8rslev-Petersen K, et al. Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone. 1996;19(2):157\u201363.","journal-title":"Bone"},{"key":"1553_CR19","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00198-017-4062-8","volume":"28","author":"P Peris","year":"2017","unstructured":"Peris P, Filella X, Monegal A, Gua\u00f1abens N, Foj L, Bonet M, et al. Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study. Osteoporos Int. 2017;28:2457\u201364.","journal-title":"Osteoporos Int"},{"issue":"1","key":"1553_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S1368980021002299","volume":"25","author":"Z G\u00f6kta\u015f","year":"2022","unstructured":"G\u00f6kta\u015f Z, Dikmen D, Rak\u0131c\u0131o\u011flu N. Validation of MEDFICTS dietary assessment questionnaire in Turkish population. Public Health Nutr. 2022;25(1):13\u20137.","journal-title":"Public Health Nutr"},{"unstructured":"Beslenme. Bilgi Sistemi - BeBiS. 2019.","key":"1553_CR21"},{"key":"1553_CR22","first-page":"2019","volume":"20","author":"TS Bakanl\u0131\u011f\u0131","year":"2015","unstructured":"Bakanl\u0131\u011f\u0131 TS. T\u00fcrkiye beslenme rehberi (T\u00dcBER). Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Yay\u0131nlar\u0131. Ankara. 2015;20:2019.","journal-title":"Ankara"},{"issue":"3","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-16-0652","volume":"176","author":"K Hygum","year":"2017","unstructured":"Hygum K, Starup-Linde J, Harsl\u00f8f T, Vestergaard P, Langdahl BL. Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover\u2013a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R137\u2013R57.","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"1553_CR24","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2169\/internalmedicine.0905-18","volume":"57","author":"I Kanazawa","year":"2018","unstructured":"Kanazawa I, Sugimoto T. Diabetes mellitus-induced bone fragility. Intern Med. 2018;57(19):2773\u201385.","journal-title":"Intern Med"},{"issue":"2","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/pedi.12963","volume":"21","author":"JO Madsen","year":"2020","unstructured":"Madsen JO, Herskin CW, Zerahn B, Jensen AK, J\u00f8rgensen NR, Olsen BS, et al. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2020;21(2):366\u201376.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"1553_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/pedi.13367","volume":"23","author":"KA Vora","year":"2022","unstructured":"Vora KA, Munns CF, Donaghue KC, Craig ME, Briody J, Benitez-Aguirre P. Childhood type 1 diabetes is associated with abnormal bone development. Pediatr Diabetes. 2022;23(6):773\u201382.","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/jbmr.4451","volume":"36","author":"AJ Eckert","year":"2021","unstructured":"Eckert AJ, Semler O, Schnabel D, K\u00f6stner K, Wurm D, Bechtold-Dalla Pozza S, et al. Bone fractures in children and young adults with type 1 diabetes: age distribution, fracture location, and the role of glycemic control. J Bone Miner Res. 2021;36(12):2371\u201380.","journal-title":"J Bone Miner Res"},{"key":"1553_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00774-009-0076-4","volume":"27","author":"K Heilman","year":"2009","unstructured":"Heilman K, Zilmer M, Zilmer K, Tillmann V. Lower bone mineral density in children with type 1 diabetes is associated with poor glycemic control and higher serum ICAM-1 and urinary isoprostane levels. J Bone Miner Metab. 2009;27:598\u2013604.","journal-title":"J Bone Miner Metab"},{"key":"1553_CR29","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","volume":"27","author":"CM Weaver","year":"2016","unstructured":"Weaver CM, Gordon CM, Janz KF, Kalkwarf H, Lappe JM, Lewis R, et al. The National Osteoporosis Foundation\u2019s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 2016;27:1281\u2013386.","journal-title":"Osteoporos Int"},{"doi-asserted-by":"crossref","unstructured":"Shim J-S, Oh K, Kim HC. Dietary assessment methods in epidemiologic studies. Epidemiol Health. 2014;36.","key":"1553_CR30","DOI":"10.4178\/epih\/e2014009"},{"issue":"1","key":"1553_CR31","doi-asserted-by":"publisher","first-page":"20063","DOI":"10.1038\/s41598-019-56541-5","volume":"9","author":"AJ Ahola","year":"2019","unstructured":"Ahola AJ, Mutter S, Forsblom C, Harjutsalo V, Groop P-H. Meal timing, meal frequency, and breakfast skipping in adult individuals with type 1 diabetes\u2013associations with glycaemic control. Sci Rep. 2019;9(1):20063.","journal-title":"Sci Rep"},{"doi-asserted-by":"crossref","unstructured":"Joshi A, Varthakavi P, Chadha M, Bhagwat N. A study of bone mineral density and its determinants in type 1 diabetes mellitus. Journal of osteoporosis. 2013;2013.","key":"1553_CR32","DOI":"10.1155\/2013\/397814"},{"key":"1553_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s001980050082","volume":"8","author":"T Miazgowski","year":"1998","unstructured":"Miazgowski T, Czekalski S. A 2-year follow-up study on bone mineral density and markers of bone turnover in patients with long-standing insulin-dependent diabetes mellitus. Osteoporos Int. 1998;8:399\u2013403.","journal-title":"Osteoporos Int"},{"issue":"4","key":"1553_CR34","first-page":"1194","volume":"80","author":"R Bouillon","year":"1995","unstructured":"Bouillon R, Bex M, Van Herck E, Laureys J, Dooms L, Lesaffre E, et al. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metabolism. 1995;80(4):1194\u2013202.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1553_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fendo.2013.00021","volume":"4","author":"J Starup-Linde","year":"2013","unstructured":"Starup-Linde J. Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol. 2013;4:21.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1553_CR36","doi-asserted-by":"publisher","first-page":"e00312","DOI":"10.1002\/edm2.312","volume":"5","author":"B Zabeen","year":"2022","unstructured":"Zabeen B, Nahar J, Ahmed B, Tayyeb S, Islam N, Azad K. Vitamin D status in children and adolescents with type 1 diabetes in a specialized diabetes care centre in Bangladesh. Endocrinol Diabetes Metabolism. 2022;5(1):e00312.","journal-title":"Endocrinol Diabetes Metabolism"},{"issue":"8","key":"1553_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/pedi.12342","volume":"17","author":"H Al-Zubeidi","year":"2016","unstructured":"Al-Zubeidi H, Leon\u2010Chi L, Newfield RS. Low vitamin D level in pediatric patients with new onset type 1 diabetes is common, especially if in ketoacidosis. Pediatr Diabetes. 2016;17(8):592\u20138.","journal-title":"Pediatr Diabetes"},{"doi-asserted-by":"crossref","unstructured":"Carakushansky M, Patel P, Khallouq BAB, Gurnurkar S. Prevalence of vitamin D deficiency in children with type 1 diabetes mellitus. Cureus. 2020;12(4).","key":"1553_CR38","DOI":"10.7759\/cureus.7836"},{"issue":"1","key":"1553_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1900\/RDS.2023.19.1","volume":"19","author":"N Bouichrat","year":"2023","unstructured":"Bouichrat N, Benyakhef S, Assarrar I, Draoui N, Lazreg Y, Abda N, et al. Vitamin D status in diabetic Moroccan children and adolescents: a case-control study. Rev Diabet Stud. 2023;19(1):1\u20137.","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"1553_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.11138\/ccmbm\/2017.14.1.209","volume":"14","author":"V Domazetovic","year":"2017","unstructured":"Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Mineral Bone Metabolism. 2017;14(2):209.","journal-title":"Clin Cases Mineral Bone Metabolism"},{"issue":"1","key":"1553_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.33176\/AACB-20-0001","volume":"42","author":"MJ Gillett","year":"2021","unstructured":"Gillett MJ, Vasikaran SD, Inderjeeth CA. The role of PINP in diagnosis and management of metabolic bone disease. Clin Biochemist Reviews. 2021;42(1):3.","journal-title":"Clin Biochemist Reviews"},{"key":"1553_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00223-017-0381-1","volume":"102","author":"R Franceschi","year":"2018","unstructured":"Franceschi R, Longhi S, Cauvin V, Fassio A, Gallo G, Lupi F, et al. Bone geometry, quality, and bone markers in children with type 1 diabetes mellitus. Calcif Tissue Int. 2018;102:657\u201365.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1553_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.diabres.2013.12.018","volume":"103","author":"MB Loureiro","year":"2014","unstructured":"Loureiro MB, Ururahy MA, Freire-Neto FP, Oliveira GH, Duarte VM, Luchessi AD, et al. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2014;103(3):452\u20137.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01553-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:46:07Z","timestamp":1718336767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01553-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01553-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"type":"electronic","value":"1472-6823"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study was approved by the University of Health Sciences Non-Interventional Clinical Research Ethics Committee (2022\/28) and supported by the University of Health Sciences Scientific Research Projects Unit (Project No: 2023\/014). In addition, patients and their families gave informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}